Gene · 3912
Papers1,743
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,743
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biomarkers predicting the efficacy of immune checkpoint inhibitors in hepatocellular carcinoma. | Front Immunol | 2023 | 38187399 | PubTator, text mining | PubMed |
| High MEIS3 Expression Indicates a Poor Prognosis for Patients with Stage II/III Colorectal Cancer. | Front Biosci (Landmark Ed) | 2023 | 38179750 | PubTator, text mining | PubMed |
| Implications of oral dysbiosis and HPV infection in head and neck cancer: from molecular and cellular mechanisms to early diagnosis and therapy. | Front Oncol | 2023 | 38179168 | PubTator, text mining | PubMed |
| Spheroid size influences cellular senescence and angiogenic potential of mesenchymal stromal cell-derived soluble factors and extracellular vesicles. | Front Bioeng Biotechnol | 2023 | 38162179 | PubTator, text mining | PubMed |
| Editorial: Enlarged perivascular spaces: etiology and significance. | Front Neurosci | 2023 | 38161800 | PubTator, text mining | PubMed |
| Anoikis regulator GLI2 promotes NC cell immunity escape by TGF-β-mediated non-classic hedgehog signaling in colorectal cancer: based on artificial intelligence and big data analysis. | Aging (Albany NY) | 2023 | 38159250 | PubTator, text mining | PubMed |
| Identification of Central Nervous System Oncologic Disease Biomarkers in EVs from Cerebrospinal Fluid (CSF) of Pediatric Patients: A Pilot Neuro-Proteomic Study. | Biomolecules | 2023 | 38136601 | PubTator, text mining | PubMed |
| Flow in fetoplacental-like microvessels in vitro enhances perfusion, barrier function, and matrix stability. | Sci Adv | 2023 | 38134282 | PubTator, text mining | PubMed |
| Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells. | Sci Rep | 2023 | 38114514 | PubTator, text mining | PubMed |
| Proton Compared to X-Irradiation Induces Different Protein Profiles in Oral Cancer Cells and Their Derived Extracellular Vesicles. | Int J Mol Sci | 2023 | 38069306 | PubTator, text mining | PubMed |
| Proteomic analysis of exosomes secreted during the epithelial-mesenchymal transition and potential biomarkers of mesenchymal high-grade serous ovarian carcinoma. | J Ovarian Res | 2023 | 38031074 | PubTator, text mining | PubMed |
| Gene-educational attainment interactions in a multi-population genome-wide meta-analysis identify novel lipid loci. | Front Genet | 2023 | 38028628 | PubTator, text mining | PubMed |
| Revealing the inhibitory effect of VASH1 on ovarian cancer from multiple perspectives. | Cancer Biol Ther | 2023 | 38010374 | PubTator, text mining | PubMed |
| Resensitizing Paclitaxel-Resistant Ovarian Cancer via Targeting Lipid Metabolism Key Enzymes CPT1A, SCD and FASN. | Int J Mol Sci | 2023 | 38003694 | PubTator, text mining | PubMed |
| Lactate receptor GPR81 drives breast cancer growth and invasiveness through regulation of ECM properties and Notch ligand DLL4. | BMC Cancer | 2023 | 37993804 | PubTator, text mining | PubMed |
| Cellular senescence triggers intracellular acidification and lysosomal pH alkalinized via ATP6AP2 attenuation in breast cancer cells. | Commun Biol | 2023 | 37993606 | PubTator, text mining | PubMed |
| Pediatric HIV+ Kaposi sarcoma exhibits clinical, virological, and molecular features different from the adult disease. | JCI Insight | 2023 | 37991023 | PubTator, text mining | PubMed |
| Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables. | Clin Proteomics | 2023 | 37990292 | PubTator, text mining | PubMed |
| Radiotranscriptomics identified new mRNAs and miRNA markers for distinguishing prostate cancer from benign prostatic hyperplasia. | Cancer Med | 2023 | 37987209 | PubTator, text mining | PubMed |
| [Screen of key characteristic genes of nasopharyngeal carcinoma (NPC) base on machine learning and analysis of their correlation with immune cells]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2023 | 37980550 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3912/papers?page=6